| 1 |
FDA Approved Drug Products from FDA Official Website. 2023. Application Number: 213871.
|
| 2 |
Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
|
| 3 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5171).
|
| 4 |
2016 FDA drug approvals. Nat Rev Drug Discov. 2017 Feb 2;16(2):73-76.
|
| 5 |
ClinicalTrials.gov (NCT00745199) Evaluating the Effect of Cromolyn Sodium in Uremic Pruritus. U.S. National Institutes of Health.
|
| 6 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7066).
|
| 7 |
2017 FDA drug approvals.Nat Rev Drug Discov. 2018 Feb;17(2):81-85.
|
| 8 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6783).
|
| 9 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 10 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6962).
|
| 11 |
ClinicalTrials.gov (NCT01359943) Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis Taking Methotrexate
|
| 12 |
ClinicalTrials.gov (NCT02564042) A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis.
|
| 13 |
FDA Approved Drug Products from FDA Official Website. 2021. Application Number: 761180.
|
| 14 |
ClinicalTrials.gov (NCT04804605) Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-OLE). U.S. National Institutes of Health.
|
| 15 |
ClinicalTrials.gov (NCT05614817) A Randomized, Double-blind, Placebo-controlled Phase 3 Trial to Evaluate the Efficacy and Safety of CBP-201 Monotherapy in Patients With Moderate-To-Severe Atopic Dermatitis Who Are Candidates for Systemic Therapy. U.S.National Institutes of Health.
|
| 16 |
ClinicalTrials.gov (NCT03989206) Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis. U.S. National Institutes of Health.
|
| 17 |
ClinicalTrials.gov (NCT05633355) A Phase 3, Open-label, 52-week Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab (AMG 451) in Adolescent Subjects Aged >= 12 to < 18 Years With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Orbit). U.S.National Institutes of Health.
|
| 18 |
ClinicalTrials.gov (NCT02134028) Long-Term Safety Evaluation of Dupilumab in Patients With Asthma. U.S. National Institutes of Health.
|
| 19 |
Emerging drugs for asthma. Expert Opin Emerg Drugs. 2008 Dec;13(4):643-53.
|
| 20 |
ClinicalTrials.gov (NCT05509023) A Randomized, Double-Blind, Placebo-Controlled Phase 2a Proof-of-Concept Study Evaluating the Safety and Efficacy of ADX-914 in Subjects With Moderate to Severe Atopic Dermatitis. U.S.National Institutes of Health.
|
| 21 |
OX40-OX40L Inhibition for the Treatment of Atopic Dermatitis-Focus on Rocatinlimab and Amlitelimab. Pharmaceutics. 2022 Dec 8;14(12):2753.
|
| 22 |
ClinicalTrials.gov (NCT01301508) Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic Dermatitis. U.S. National Institutes of Health.
|
| 23 |
Clinical pipeline report, company report or official report of Anacor Pharmaceuticals.
|
| 24 |
ClinicalTrials.gov (NCT01756898) A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis. U.S. National Institutes of Health.
|
| 25 |
ClinicalTrials.gov (NCT03759340) ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT). U.S. National Institutes of Health.
|
| 26 |
ClinicalTrials.gov (NCT00883311) A Study of BRT-FC-83C for the Treatment of Atopic Dermatitis. U.S. National Institutes of Health.
|
| 27 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800024035)
|
| 28 |
ClinicalTrials.gov (NCT01447017) A Study of DPK-060 to Investigate Clinical Safety and Efficacy in Patients With Acute External Otitis. U.S. National Institutes of Health.
|
| 29 |
ClinicalTrials.gov (NCT01461941) A Phase 2 Study of E6005 in Patients With Atopic Dermatitis. U.S. National Institutes of Health.
|
| 30 |
ClinicalTrials.gov (NCT01299610) A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo. U.S. National Institutes of Health.
|
| 31 |
ClinicalTrials.gov (NCT01568489) Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis. U.S. National Institutes of Health.
|
| 32 |
ClinicalTrials.gov (NCT00455429) An Efficacy and Safety Study of JNJ-26113100 in the Treatment of Adult Atopic Dermatitis. U.S. National Institutes of Health.
|
| 33 |
ClinicalTrials.gov (NCT01067833) Phase 2 Study of Oral K201 for Prevention of AF Recurrence. U.S. National Institutes of Health.
|
| 34 |
ClinicalTrials.gov (NCT01119339) Study to Investigate Dose-related Efficacy of LAS41004 in the Treatment of Psoriasis. U.S. National Institutes of Health.
|
| 35 |
ClinicalTrials.gov (NCT01037881) LEO 29102 Cream in the Treatment of Atopic Dermatitis. U.S. National Institutes of Health.
|
| 36 |
Clinical pipeline report, company report or official report of NicOx SA.
|
| 37 |
ClinicalTrials.gov (NCT02052531) Efficacy and Safety Study of PAC-14028 Cream in Dermal Pruritus. U.S. National Institutes of Health.
|
| 38 |
ClinicalTrials.gov (NCT05375955) A PHASE 2B, RANDOMIZED, DOUBLE BLIND, VEHICLE CONTROLLED, PARALLEL GROUP STUDY TO ASSESS THE EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF MULTIPLE DOSE LEVELS OF PF-07038124 OINTMENT FOR 12 WEEKS IN PARTICIPANTS 12 YEARS AND OLDER AND WITH MILD-TO-MODERATE ATOPIC DERMATITIS OR MILD-TO-SEVERE PLAQUE PSORIASIS. U.S.National Institutes of Health.
|
| 39 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 579).
|
| 40 |
ClinicalTrials.gov (NCT03571620) Safety and Efficacy Study of Q301 in Mild to Moderate Adolescents and Adults Atopic Dermatitis Patients. U.S. National Institutes of Health.
|
| 41 |
Emerging drugs for atopic dermatitis. Expert Opin Emerg Drugs. 2009 Mar;14(1):165-79.
|
| 42 |
ClinicalTrials.gov (NCT04992546) A Randomized, Intra-patient, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic Dermatitis. U.S.National Institutes of Health.
|
| 43 |
ClinicalTrials.gov (NCT00882245) Safety and Efficacy of SRD441 Ointment in Patients With Atopic Dermatitis. U.S. National Institutes of Health.
|
| 44 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800024588)
|
| 45 |
ClinicalTrials.gov (NCT00914186) Study of TS-022 in Adult Patients With Atopic Dermatitis With Pruritus (POC). U.S. National Institutes of Health.
|
| 46 |
ClinicalTrials.gov (NCT05277571) A Phase 1/2A, Randomized, Placebo-Controlled, Single-Ascending Dose (Part A, Participant- and Investigator-Blind) and Repeat-Dose (Part B, Participant-, Investigator-, and Sponsor-Blind) Study to Investigate the Safety, Pharmacokinetics, and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B). U.S.National Institutes of Health.
|
| 47 |
ClinicalTrials.gov (NCT05656911) A Randomized, Placebo-controlled, Double-blind, Parallel-group, Multicenter Phase 2a Study to Investigate Efficacy and Safety of Zabedosertib (BAY 1834845) for the Treatment of Adult Patients With Moderate-to-severe Atopic Dermatitis. U.S.National Institutes of Health.
|
| 48 |
ClinicalTrials.gov (NCT00932074) A Study to Determine the Safety, Tolerability and Efficacy of KP 13 in Subjects With Atopic Dermatitis(AD). U.S. National Institutes of Health.
|
| 49 |
ClinicalTrials.gov (NCT01605708) Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis. U.S. National Institutes of Health.
|
| 50 |
ClinicalTrials.gov (NCT04668066) A PHASE 1 FIRST IN HUMAN, RANDOMIZED, DOUBLE BLIND, SPONSOR OPEN, PLACEBO-CONTROLLED, SINGLE- AND MULTIPLE DOSE ESCALATION, PARALLEL GROUP STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF PF 07242813 IN HEALTHY PARTICIPANTS AND PARTICIPANTS WITH ATOPIC DERMATITIS. U.S.National Institutes of Health.
|
| 51 |
ClinicalTrials.gov (NCT05496738) A PHASE 1, RANDOMIZED, DOUBLE-BLIND, SPONSOR-OPEN, PLACEBO-CONTROLLED, DOSE-ESCALATING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SINGLE AND MULTIPLE INTRAVENOUS AND SUBCUTANEOUS DOSES OF PF-07264660 IN HEALTHY PARTICIPANTS. U.S.National Institutes of Health.
|
| 52 |
ClinicalTrials.gov (NCT05411588) A PHASE 1, RANDOMIZED, DOUBLE-BLIND, SPONSOR OPEN, PLACEBO-CONTROLLED, DOSE ESCALATING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SINGLE AND MULTIPLE INTRAVENOUS AND SUBCUTANEOUS DOSES OF PF-07275315 IN HEALTHY PARTICIPANTS. U.S.National Institutes of Health.
|
| 53 |
ClinicalTrials.gov (NCT05206604) A PHASE 1, RANDOMIZED, DOUBLE-BLIND, SPONSOR-OPEN, VEHICLE-CONTROLLED, FIRST-IN-HUMAN, MULTIPLE-DOSE STUDY, TO INVESTIGATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS, OF TOPICALLY ADMINISTERED PF-07295324 AND PF-07259955, IN HEALTHY ADULT PARTICIPANTS. U.S.National Institutes of Health.
|
| 54 |
Clinical pipeline report, company report or official report of Sanofi
|
| 55 |
Clinical pipeline report, company report or official report of Siolta Therapeutics.
|
| 56 |
ClinicalTrials.gov (NCT04643457) A Phase I/IIA, Randomized, Placebo-Controlled, Single-Ascending Dose (Part A, Participant- and Investigator-Blind) and Repeated-Dose (Part B, Participant-, Investigator-, and Sponsor-Blind) Study to Investigate the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants (Part A) and in Study Participants With Moderate-to-Severe Atopic Dermatitis (Part B). U.S.National Institutes of Health.
|
| 57 |
Protease activated receptor 2 (PAR2) modulators: a patent review (2010-2015).Expert Opin Ther Pat. 2016;26(4):471-83.
|
| 58 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006996)
|
| 59 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014452)
|
| 60 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018071)
|
| 61 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008118)
|
| 62 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 282).
|
| 63 |
The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
|
| 64 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2372).
|
| 65 |
Effect of orally administered KF66490, a phosphodiesterase 4 inhibitor, on dermatitis in mouse models. Int Immunopharmacol. 2009 Jan;9(1):55-62.
|
| 66 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2767).
|
| 67 |
Methyl--cyclodextrin treatment combined to incubation with interleukin-4 reproduces major features of atopic dermatitis in a 3D-culture model.Arch Dermatol Res. 2017 Jan;309(1):63-69. doi: 10.1007/s00403-016-1699-7. Epub 2016 Nov 11.
|
| 68 |
A Molluscum contagiosum fusion protein inhibits CCL1-induced chemotaxis of cells expressing CCR8 and penetrates human neonatal foreskins: clinical applications proposed.Arch Dermatol Res. 2015 Apr;307(3):275-80. doi: 10.1007/s00403-014-1516-0. Epub 2014 Nov 11.
|
| 69 |
CD1a presentation of endogenous antigens by group 2 innate lymphoid cells.Sci Immunol. 2017 Dec 22;2(18):eaan5918. doi: 10.1126/sciimmunol.aan5918.
|
| 70 |
Regulation of claudin-4 via p63 in human epithelial cells.Ann N Y Acad Sci. 2017 Oct;1405(1):25-31. doi: 10.1111/nyas.13456. Epub 2017 Aug 30.
|
| 71 |
Human Adipose Tissue-Derived Mesenchymal Stem Cells Attenuate Atopic Dermatitis by Regulating the Expression of MIP-2, miR-122a-SOCS1 Axis, and Th1/Th2 Responses.Front Pharmacol. 2018 Nov 6;9:1175. doi: 10.3389/fphar.2018.01175. eCollection 2018.
|
| 72 |
A Promoter Polymorphism of the Vitamin D Metabolism Gene Cyp24a1 is Associated with Severe Atopic Dermatitis in Adults.Acta Derm Venereol. 2016 Feb;96(2):169-72. doi: 10.2340/00015555-2226.
|
| 73 |
Thymic stromal lymphopoietin epigenetically upregulates Fc receptor subunit-related receptors on antigen-presenting cells and induces T(H)2/T(H)17 polarization through dectin-2.J Allergy Clin Immunol. 2019 Oct;144(4):1025-1035.e7. doi: 10.1016/j.jaci.2019.06.011. Epub 2019 Jun 25.
|
| 74 |
Dichotomic nature of atopic dermatitis reflected by combined analysis of monocyte immunophenotyping and single nucleotide polymorphisms of the interleukin-4/interleukin-13 receptor gene: the dichotomy of extrinsic and intrinsic atopic dermatitis.J Invest Dermatol. 2002 Oct;119(4):870-5. doi: 10.1046/j.1523-1747.2002.00191.x.
|
| 75 |
MicroRNA-223 is involved in the pathogenesis of atopic dermatitis by affecting histamine-N-methyltransferase.Cell Mol Biol (Noisy-le-grand). 2018 Feb 28;64(3):103-107. doi: 10.14715/cmb/2018.64.3.17.
|
| 76 |
Disparity of innate immunity-related gene effects on asthma and allergy on Karelia.Pediatr Allergy Immunol. 2011 Sep;22(6):621-30. doi: 10.1111/j.1399-3038.2011.01186.x. Epub 2011 Jul 13.
|
| 77 |
Association of polymorphisms in genes encoding IL-4, IL-13 and their receptors with atopic dermatitis in a Korean population.Exp Dermatol. 2011 Nov;20(11):915-9. doi: 10.1111/j.1600-0625.2011.01357.x. Epub 2011 Sep 14.
|
| 78 |
Scratching Counteracts IL-13 Signaling by Upregulating the Decoy Receptor IL-13R2 in Keratinocytes.Int J Mol Sci. 2019 Jul 6;20(13):3324. doi: 10.3390/ijms20133324.
|
| 79 |
Interleukin-33 serum levels in postmenopausal women with osteoporosis.Sci Rep. 2019 Mar 7;9(1):3786. doi: 10.1038/s41598-019-40212-6.
|
| 80 |
Endoplasmic reticulum aminopeptidase 1 polymorphism Ile276Met is associated with atopic dermatitis and affects the generation of an HLA-C associated antigenic epitope in vitro.J Eur Acad Dermatol Venereol. 2019 May;33(5):906-911. doi: 10.1111/jdv.15449. Epub 2019 Mar 4.
|
| 81 |
Ustekinumab treatment in severe atopic dermatitis: Down-regulation of T-helper 2/22 expression.J Am Acad Dermatol. 2017 Jan;76(1):91-97.e3. doi: 10.1016/j.jaad.2016.07.047. Epub 2016 Oct 13.
|
| 82 |
Genome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms.Am J Hum Genet. 2015 Jan 8;96(1):104-20. doi: 10.1016/j.ajhg.2014.12.004.
|
| 83 |
Vaccinia virus-specific molecular signature in atopic dermatitis skin.J Allergy Clin Immunol. 2010 Jan;125(1):153-159.e28. doi: 10.1016/j.jaci.2009.10.024.
|
| 84 |
Interaction of NPSR1 genotypes and probiotics in the manifestation of atopic eczema in early childhood.Allergol Immunopathol (Madr). 2014 Nov-Dec;42(6):560-7. doi: 10.1016/j.aller.2013.10.001. Epub 2014 Jan 14.
|
| 85 |
Neurotensin serum levels and skin gene expression are increased in atopic dermatitis.Br J Dermatol. 2013 Sep;169(3):695-9. doi: 10.1111/bjd.12413.
|
| 86 |
Spirodela polyrhiza extract modulates the activation of atopic dermatitis-related ion channels, Orai1 and TRPV3, and inhibits mast cell degranulation.Pharm Biol. 2017 Dec;55(1):1324-1329. doi: 10.1080/13880209.2017.1300819.
|
| 87 |
Bee Venom Phospholipase A2 Alleviate House Dust Mite-Induced Atopic Dermatitis-Like Skin Lesions by the CD206 Mannose Receptor.Toxins (Basel). 2018 Apr 2;10(4):146. doi: 10.3390/toxins10040146.
|
| 88 |
Usefulness of a global clinical ichthyosis vulgaris scoring system for predicting common FLG null mutations in an adult caucasian population.Br J Dermatol. 2012 Nov;167(5):1165-9. doi: 10.1111/j.1365-2133.2012.11062.x. Epub 2012 Sep 7.
|
| 89 |
PGH1, the precursor for the anti-inflammatory prostaglandins of the 1-series, is a potent activator of the pro-inflammatory receptor CRTH2/DP2.PLoS One. 2012;7(3):e33329. doi: 10.1371/journal.pone.0033329. Epub 2012 Mar 19.
|
| 90 |
Association analysis of sphingomyelinase 2 polymorphisms for the extrinsic type of atopic dermatitis in Koreans.J Dermatol Sci. 2007 May;46(2):143-6. doi: 10.1016/j.jdermsci.2006.12.001. Epub 2007 Jan 8.
|
| 91 |
Lack of primary association between transporter associated with antigen processing genes and atopic dermatitis.J Allergy Clin Immunol. 1995 Dec;96(6 Pt 2):1051-60. doi: 10.1016/s0091-6749(95)70190-7.
|
| 92 |
Association of thromboxane A2 receptor (TBXA2R) gene polymorphism in patients with aspirin-intolerant acute urticaria.Clin Exp Allergy. 2011 Feb;41(2):179-85. doi: 10.1111/j.1365-2222.2010.03642.x. Epub 2010 Nov 11.
|
| 93 |
LIGHT-HVEM signaling in keratinocytes controls development of dermatitis.J Exp Med. 2018 Feb 5;215(2):415-422. doi: 10.1084/jem.20170536. Epub 2018 Jan 16.
|
| 94 |
The Immunosuppressant Macrolide Tacrolimus Activates Cold-Sensing TRPM8 Channels.J Neurosci. 2019 Feb 6;39(6):949-969. doi: 10.1523/JNEUROSCI.1726-18.2018. Epub 2018 Dec 13.
|
| 95 |
Serum IL-21 levels are elevated in atopic dermatitis patients with acute skin lesions.Allergol Int. 2017 Jul;66(3):440-444. doi: 10.1016/j.alit.2016.10.010. Epub 2016 Nov 22.
|
| 96 |
Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1. Redox Biol. 2020 Jan;28:101321. doi: 10.1016/j.redox.2019.101321. Epub 2019 Sep 5.
|
| 97 |
Cordycepin ameliorates skin inflammation in a DNFB-challenged murine model of atopic dermatitis.Immunopharmacol Immunotoxicol. 2018 Oct;40(5):401-407. doi: 10.1080/08923973.2018.1510964. Epub 2018 Sep 5.
|
| 98 |
Expression of the collagen VI 5 and 6 chains in normal human skin and in skin of patients with collagen VI-related myopathies.J Invest Dermatol. 2011 Jan;131(1):99-107. doi: 10.1038/jid.2010.284. Epub 2010 Sep 30.
|
| 99 |
Neutrophils promote CXCR3-dependent itch in the development of atopic dermatitis.Elife. 2019 Oct 21;8:e48448. doi: 10.7554/eLife.48448.
|
| 100 |
Signaling via the IL-20 receptor inhibits cutaneous production of IL-1 and IL-17A to promote infection with methicillin-resistant Staphylococcus aureus.Nat Immunol. 2013 Aug;14(8):804-11. doi: 10.1038/ni.2637. Epub 2013 Jun 23.
|
| 101 |
Activation of RhoA, Smad2, c-Src, PKC-II/ and JNK in atopic dermatitis.Australas J Dermatol. 2018 Nov;59(4):e258-e261. doi: 10.1111/ajd.12801. Epub 2018 Mar 2.
|
| 102 |
ZAG Regulates the Skin Barrier and Immunity in Atopic Dermatitis.J Invest Dermatol. 2019 Aug;139(8):1648-1657.e7. doi: 10.1016/j.jid.2019.01.023. Epub 2019 Feb 6.
|
| 103 |
ADAM33 genetic polymorphisms and risk of atopic dermatitis among Japanese children.Clin Biochem. 2009 Apr;42(6):477-83. doi: 10.1016/j.clinbiochem.2008.12.014. Epub 2008 Dec 31.
|
| 104 |
Intermedin: a skin peptide that is downregulated in atopic dermatitis.J Invest Dermatol. 2007 Mar;127(3):605-13. doi: 10.1038/sj.jid.5700576. Epub 2006 Sep 28.
|
| 105 |
Transcriptomic and lipidomic profiling of eicosanoid/docosanoid signalling in affected and non-affected skin of human atopic dermatitis patients.Exp Dermatol. 2019 Feb;28(2):177-189. doi: 10.1111/exd.13867.
|
| 106 |
An aquaporin 3-notch1 axis in keratinocyte differentiation and inflammation.PLoS One. 2013 Nov 8;8(11):e80179. doi: 10.1371/journal.pone.0080179. eCollection 2013.
|
| 107 |
Nonclinical Safety and Toxicokinetics of MnTE-2-PyP (BMX-010), a Topical Agent in Phase 2 Trials for Psoriasis and Atopic Dermatitis.Int J Toxicol. 2019 Jul/Aug;38(4):291-302. doi: 10.1177/1091581819852325.
|
| 108 |
Glyoxal-induced exacerbation of pruritus and dermatitis is associated with staphylococcus aureus colonization in the skin of a rat model of atopic dermatitis.J Dermatol Sci. 2018 Jun;90(3):276-283. doi: 10.1016/j.jdermsci.2018.02.012. Epub 2018 Feb 21.
|
| 109 |
Use of Physcion to Improve Atopic Dermatitis-Like Skin Lesions through Blocking of Thymic Stromal Lymphopoietin.Molecules. 2019 Apr 15;24(8):1484. doi: 10.3390/molecules24081484.
|
| 110 |
Development of atopic dermatitis-like skin disease from the chronic loss of epidermal caspase-8.Proc Natl Acad Sci U S A. 2010 Dec 21;107(51):22249-54. doi: 10.1073/pnas.1009751108. Epub 2010 Dec 6.
|
| 111 |
Increased cardiovascular and atherosclerosis markers in blood of older patients with atopic dermatitis.Ann Allergy Asthma Immunol. 2020 Jan;124(1):70-78. doi: 10.1016/j.anai.2019.10.013. Epub 2019 Oct 14.
|
| 112 |
Distinct transcriptomic profiles of early-onset atopic dermatitis in blood and skin of pediatric patients.Ann Allergy Asthma Immunol. 2019 Mar;122(3):318-330.e3. doi: 10.1016/j.anai.2018.11.025. Epub 2018 Dec 1.
|
| 113 |
CCL23 expression is induced by IL-4 in a STAT6-dependent fashion.J Immunol. 2007 Apr 1;178(7):4335-41. doi: 10.4049/jimmunol.178.7.4335.
|
| 114 |
Investigation of Immune-Regulatory Effects of Mageumsan Hot Spring via Protein Microarray In Vitro.Ann Dermatol. 2018 Jun;30(3):322-330. doi: 10.5021/ad.2018.30.3.322. Epub 2018 Apr 23.
|
| 115 |
RANTES gene polymorphisms are not associated with rheumatoid arthritis and atopic dermatitis: a meta-analysis.Int Rev Immunol. 2015;34(6):500-8. doi: 10.3109/08830185.2014.994815. Epub 2015 Jan 21.
|
| 116 |
Peroxisome proliferator-activated receptor alpha regulates skin inflammation and humoral response in atopic dermatitis.J Allergy Clin Immunol. 2008 Apr;121(4):962-8.e6. doi: 10.1016/j.jaci.2007.12.1165. Epub 2008 Feb 4.
|
| 117 |
The Toll-like receptor 2 R753Q mutation modifies cytokine production and Toll-like receptor expression in atopic dermatitis.J Allergy Clin Immunol. 2008 Apr;121(4):1013-9. doi: 10.1016/j.jaci.2007.11.029. Epub 2008 Jan 30.
|
| 118 |
Association study of mast cell chymase polymorphisms with atopy.Allergy. 2005 Oct;60(10):1256-61. doi: 10.1111/j.1398-9995.2005.00879.x.
|
| 119 |
Association of cathepsin E deficiency with development of atopic dermatitis.J Biochem. 2003 Dec;134(6):893-902. doi: 10.1093/jb/mvg216.
|
| 120 |
A mechanistic target of rapamycin complex 1/2 (mTORC1)/V-Akt murine thymoma viral oncogene homolog 1 (AKT1)/cathepsin H axis controls filaggrin expression and processing in skin, a novel mechanism for skin barrier disruption in patients with atopic dermatitis.J Allergy Clin Immunol. 2017 Apr;139(4):1228-1241. doi: 10.1016/j.jaci.2016.09.052. Epub 2016 Nov 29.
|
| 121 |
The cystatin M/E-controlled pathway of skin barrier formation: expression of its key components in psoriasis and atopic dermatitis.Br J Dermatol. 2009 Aug;161(2):253-64. doi: 10.1111/j.1365-2133.2009.09156.x. Epub 2009 Apr 24.
|
| 122 |
Gene expression profiling of lichen planus reflects CXCL9+-mediated inflammation and distinguishes this disease from atopic dermatitis and psoriasis.J Invest Dermatol. 2008 Jan;128(1):67-78. doi: 10.1038/sj.jid.5700945. Epub 2007 Aug 16.
|
| 123 |
927T>C polymorphism of the cysteinyl-leukotriene type-1 receptor (CYSLTR1) gene in children with asthma and atopic dermatitis.Pediatr Allergy Immunol. 2006 Aug;17(5):323-8. doi: 10.1111/j.1399-3038.2006.00416.x.
|
| 124 |
Update on protease-activated receptor 2 in cutaneous barrier, differentiation, tumorigenesis and pigmentation, and its role in related dermatologic diseases.Exp Dermatol. 2019 Aug;28(8):877-885. doi: 10.1111/exd.13936. Epub 2019 May 15.
|
| 125 |
IL-4 driven transcription factor FoxQ1 is expressed by monocytes in atopic dermatitis and stimulates monocyte migration.Sci Rep. 2017 Dec 4;7(1):16847. doi: 10.1038/s41598-017-17307-z.
|
| 126 |
GATA3 regulates FLG and FLG2 expression in human primary keratinocytes.Sci Rep. 2017 Sep 19;7(1):11847. doi: 10.1038/s41598-017-10252-x.
|
| 127 |
Association of Genetic Polymorphisms with Atopic Dermatitis, Clinical Severity and Total IgE: A Replication and Extended Study.Allergy Asthma Immunol Res. 2018 Jul;10(4):397-405. doi: 10.4168/aair.2018.10.4.397.
|
| 128 |
Discovery of a Novel Highly Selective Histamine H4 Receptor Antagonist for the Treatment of Atopic Dermatitis.J Med Chem. 2018 Apr 12;61(7):2949-2961. doi: 10.1021/acs.jmedchem.7b01855. Epub 2018 Apr 3.
|
| 129 |
Neuroimmune mechanisms in patients with atopic dermatitis during chronic stress.J Eur Acad Dermatol Venereol. 2008 Jan;22(1):11-8. doi: 10.1111/j.1468-3083.2007.02202.x.
|
| 130 |
T helper 22 cells from Han Chinese patients with atopic dermatitis exhibit high expression of inducible T-cell costimulator.Br J Dermatol. 2020 Mar;182(3):648-657. doi: 10.1111/bjd.18040. Epub 2019 Aug 19.
|
| 131 |
Genetic variations in IL28B and allergic disease in children.PLoS One. 2012;7(1):e30607. doi: 10.1371/journal.pone.0030607. Epub 2012 Jan 25.
|
| 132 |
Meta-analysis identifies seven susceptibility loci involved in the atopic march.Nat Commun. 2015 Nov 6;6:8804. doi: 10.1038/ncomms9804.
|
| 133 |
Inhibition of S100A11 gene expression impairs keratinocyte response against vaccinia virus through downregulation of the IL-10 receptor 2 chain.J Allergy Clin Immunol. 2009 Aug;124(2):270-7, 277.e1. doi: 10.1016/j.jaci.2009.05.002. Epub 2009 Jul 3.
|
| 134 |
Association of single nucleotide polymorphisms in the IL-12 (IL-12A and B) and IL-12 receptor (IL-12Rbeta1 and beta2) genes and gene-gene interactions with atopic dermatitis in Koreans.J Dermatol Sci. 2010 Mar;57(3):199-206. doi: 10.1016/j.jdermsci.2009.12.003. Epub 2010 Jan 8.
|
| 135 |
The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins.Sci Rep. 2017 Aug 18;7(1):8707. doi: 10.1038/s41598-017-09207-z.
|
| 136 |
Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis.Nat Genet. 2015 Dec;47(12):1449-1456. doi: 10.1038/ng.3424. Epub 2015 Oct 19.
|
| 137 |
Genome-wide association studies of allergic diseases.Allergol Int. 2013 Mar;62(1):21-8. doi: 10.2332/allergolint.13-RAI-0539.
|
| 138 |
IL-21R is essential for epicutaneous sensitization and allergic skin inflammation in humans and mice.J Clin Invest. 2009 Jan;119(1):47-60. doi: 10.1172/JCI32310. Epub 2008 Dec 15.
|
| 139 |
Pathophysiology of atopic dermatitis: Clinical implications.Allergy Asthma Proc. 2019 Mar 1;40(2):84-92. doi: 10.2500/aap.2019.40.4202.
|
| 140 |
Eupatilin, an activator of PPAR, inhibits the development of oxazolone-induced atopic dermatitis symptoms in Balb/c mice.Biochem Biophys Res Commun. 2018 Feb 5;496(2):508-514. doi: 10.1016/j.bbrc.2018.01.098. Epub 2018 Jan 17.
|
| 141 |
Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus.J Allergy Clin Immunol. 2020 Jan;145(1):173-182. doi: 10.1016/j.jaci.2019.08.013. Epub 2019 Aug 23.
|
| 142 |
IL-4 Augments IL-31/IL-31 Receptor Alpha Interaction Leading to Enhanced Ccl 17 and Ccl 22 Production in Dendritic Cells: Implications for Atopic Dermatitis.Int J Mol Sci. 2019 Aug 20;20(16):4053. doi: 10.3390/ijms20164053.
|
| 143 |
Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa.Br J Dermatol. 2017 Nov;177(5):1358-1366. doi: 10.1111/bjd.15458. Epub 2017 Sep 27.
|
| 144 |
Increased interleukin-36 expression in skin and sera of patients with atopic dermatitis and mycosis fungoides/Szary syndrome.J Dermatol. 2018 Apr;45(4):468-471. doi: 10.1111/1346-8138.14198. Epub 2018 Jan 3.
|
| 145 |
Insight into interleukin-37: The potential therapeutic target in allergic diseases.Cytokine Growth Factor Rev. 2019 Oct;49:32-41. doi: 10.1016/j.cytogfr.2019.10.003. Epub 2019 Oct 18.
|
| 146 |
Inflammatory alopecia in patients on dupilumab: a retrospective cohort study at an academic institution.J Eur Acad Dermatol Venereol. 2020 Apr;34(4):e159-e161. doi: 10.1111/jdv.16094. Epub 2019 Dec 20.
|
| 147 |
Protein-coding variants contribute to the risk of atopic dermatitis and skin-specific gene expression.J Allergy Clin Immunol. 2020 Apr;145(4):1208-1218. doi: 10.1016/j.jaci.2019.10.030. Epub 2019 Nov 9.
|
| 148 |
Th9 Cells in Allergic Disease.Curr Allergy Asthma Rep. 2019 Mar 26;19(5):29. doi: 10.1007/s11882-019-0860-8.
|
| 149 |
Itch gene polymorphisms in healthy population and in patients affected by rheumatoid arthritis and atopic dermatitis.Cell Cycle. 2008 Nov 15;7(22):3607-9. doi: 10.4161/cc.7.22.6968. Epub 2008 Nov 9.
|
| 150 |
Identification of highly expressed genes in peripheral blood T cells from patients with atopic dermatitis.Int Arch Allergy Immunol. 2002 Dec;129(4):327-40. doi: 10.1159/000067589.
|
| 151 |
Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream.J Allergy Clin Immunol. 2020 Feb;145(2):572-582. doi: 10.1016/j.jaci.2019.08.042. Epub 2019 Oct 17.
|
| 152 |
Superoxide Dismutase 3 Inhibits LL-37/KLK-5-Mediated Skin Inflammation through Modulation of EGFR and Associated Inflammatory Cascades.J Invest Dermatol. 2020 Mar;140(3):656-665.e8. doi: 10.1016/j.jid.2019.08.434. Epub 2019 Aug 26.
|
| 153 |
A proinflammatory role of KLK6 protease in Netherton syndrome.J Dermatol Sci. 2019 Jul;95(1):28-35. doi: 10.1016/j.jdermsci.2019.06.004. Epub 2019 Jun 16.
|
| 154 |
Exonic mutations associated with atopic dermatitis disrupt lympho-epithelial Kazal-type related inhibitor action and enhance its degradation.Allergy. 2020 Feb;75(2):403-411. doi: 10.1111/all.14018. Epub 2019 Sep 9.
|
| 155 |
Screening for key genes associated with atopic dermatitis with DNA microarrays.Mol Med Rep. 2014 Mar;9(3):1049-55. doi: 10.3892/mmr.2014.1908. Epub 2014 Jan 21.
|
| 156 |
Identification of unique proteomic signatures in allergic and non-allergic skin disease.Clin Exp Allergy. 2017 Nov;47(11):1456-1467. doi: 10.1111/cea.12979. Epub 2017 Aug 11.
|
| 157 |
EMSY expression affects multiple components of the skin barrier with relevance to atopic dermatitis.J Allergy Clin Immunol. 2019 Aug;144(2):470-481. doi: 10.1016/j.jaci.2019.05.024. Epub 2019 May 31.
|
| 158 |
The role of leukotriene B(4) in allergic diseases.Allergol Int. 2008 Dec;57(4):291-8. doi: 10.2332/allergolint.08-RAI-0019. Epub 2008 Dec 1.
|
| 159 |
Lactoferricin/verbascoside topical emulsion: a possible alternative treatment for atopic dermatitis in dogs.Nat Prod Res. 2018 Sep;32(17):2107-2110. doi: 10.1080/14786419.2017.1365066. Epub 2017 Aug 28.
|
| 160 |
The Wiskott-Aldrich syndrome gene as a candidate gene for atopic dermatitis.Acta Derm Venereol. 2001 Oct-Nov;81(5):340-2. doi: 10.1080/000155501317140043.
|
| 161 |
An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90).J Allergy Clin Immunol. 2000 Jul;106(1 Pt 1):167-70. doi: 10.1067/mai.2000.107935.
|
| 162 |
Different hypersensitivities against homologous proteins of MGL_1304 in patients with atopic dermatitis.Allergol Int. 2018 Jan;67(1):103-108. doi: 10.1016/j.alit.2017.05.009. Epub 2017 Jun 24.
|
| 163 |
Single Nucleotide Polymorphisms in the FADS Gene Cluster but not the ELOVL2 Gene are Associated with Serum Polyunsaturated Fatty Acid Composition and Development of Allergy (in a Swedish Birth Cohort).Nutrients. 2015 Dec 3;7(12):10100-15. doi: 10.3390/nu7125521.
|
| 164 |
The N-Acylethanolamine Acid Amidase Inhibitor ARN077 Suppresses Inflammation and Pruritus in a Mouse Model of AllergicDermatitis.J Invest Dermatol. 2018 Mar;138(3):562-569. doi: 10.1016/j.jid.2017.07.853. Epub 2017 Oct 18.
|
| 165 |
IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice.Mol Cell Biol. 1996 May;16(5):2341-9. doi: 10.1128/MCB.16.5.2341.
|
| 166 |
Targeting PAR2 with Pepducins.J Invest Dermatol. 2019 Feb;139(2):282-284. doi: 10.1016/j.jid.2018.09.008. Epub 2018 Nov 22.
|
| 167 |
Neurotrophin-4 production by human epidermal keratinocytes: increased expression in atopic dermatitis.J Invest Dermatol. 2000 Jun;114(6):1108-12. doi: 10.1046/j.1523-1747.2000.00974.x.
|
| 168 |
Lipid abnormalities in atopic skin are driven by type 2 cytokines.JCI Insight. 2018 Feb 22;3(4):e98006. doi: 10.1172/jci.insight.98006. eCollection 2018 Feb 22.
|
| 169 |
Evaluating crisaborole as a treatment option for atopic dermatitis.Expert Opin Pharmacother. 2019 Jun;20(9):1057-1063. doi: 10.1080/14656566.2019.1604688. Epub 2019 Apr 19.
|
| 170 |
A Novel Catecholopyrimidine Based Small Molecule PDE4B Inhibitor Suppresses Inflammatory Cytokines in Atopic Mice.Front Pharmacol. 2018 May 11;9:485. doi: 10.3389/fphar.2018.00485. eCollection 2018.
|
| 171 |
Phosphodiesterase 7A: a new therapeutic target for alleviating chronic inflammation?.Curr Pharm Des. 2006;12(25):3207-20. doi: 10.2174/138161206778194123.
|
| 172 |
MAP17 is associated with the T-helper cell cytokine-induced down-regulation of filaggrin transcription in human keratinocytes.Exp Dermatol. 2010 Apr;19(4):355-62. doi: 10.1111/j.1600-0625.2009.00902.x. Epub 2009 Jul 8.
|
| 173 |
Evaluation of periostin level for predicting severity and chronicity of childhood atopic dermatitis.Postepy Dermatol Alergol. 2019 Oct;36(5):616-619. doi: 10.5114/ada.2018.79728. Epub 2019 Nov 12.
|
| 174 |
Protective role of peroxisome proliferator-activated receptor agonists in skin barrier and inflammation.Immunobiology. 2018 Mar;223(3):327-330. doi: 10.1016/j.imbio.2017.10.047. Epub 2017 Oct 27.
|
| 175 |
Association of vitamin D receptor gene polymorphisms with severe atopic dermatitis in adults.Br J Dermatol. 2013 Apr;168(4):855-8. doi: 10.1111/bjd.12077. Epub 2013 Mar 13.
|
| 176 |
Atopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of Notch signaling in the murine skin.PLoS One. 2010 Feb 18;5(2):e9258. doi: 10.1371/journal.pone.0009258.
|
| 177 |
Deficient translocation of c-Rel is associated with impaired Th1 cytokine production in T cells from atopic dermatitis patients.Exp Dermatol. 2005 Jan;14(1):17-25. doi: 10.1111/j.0906-6705.2005.00241.x.
|
| 178 |
Atopic dermatitis in African American patients is T(H)2/T(H)22-skewed with T(H)1/T(H)17 attenuation.Ann Allergy Asthma Immunol. 2019 Jan;122(1):99-110.e6. doi: 10.1016/j.anai.2018.08.024. Epub 2018 Sep 14.
|
| 179 |
Association between asthma-related phenotypes and the CC16 A38G polymorphism in an unselected population of young adult Danes.Immunogenetics. 2005 Apr;57(1-2):25-32. doi: 10.1007/s00251-005-0778-2. Epub 2005 Mar 3.
|
| 180 |
Contribution of selectin ligands to eosinophil recruitment into the skin of patients with atopic dermatitis.Eur J Immunol. 2002 May;32(5):1274-81. doi: 10.1002/1521-4141(200205)32:5<1274::AID-IMMU1274>3.0.CO;2-Q.
|
| 181 |
STAT-6-mediated control of P-selectin by substance P and interleukin-4 in human dermal endothelial cells.Am J Pathol. 2006 Aug;169(2):697-707. doi: 10.2353/ajpath.2006.051211.
|
| 182 |
Association of Key Genes and Pathways with Atopic Dermatitis by Bioinformatics Analysis.Med Sci Monit. 2019 Jun 11;25:4353-4361. doi: 10.12659/MSM.916525.
|
| 183 |
Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis.J Allergy Clin Immunol. 2014 Oct;134(4):781-791.e1. doi: 10.1016/j.jaci.2014.05.048. Epub 2014 Aug 15.
|
| 184 |
Association between serotonin transporter gene polymorphisms and childhood asthma.J Asthma. 2013 Dec;50(10):1031-5. doi: 10.3109/02770903.2013.834503. Epub 2013 Sep 25.
|
| 185 |
Heme oxygenase-1 inhibits T cell-dependent skin inflammation and differentiation and function of antigen-presenting cells.Exp Dermatol. 2007 Aug;16(8):661-70. doi: 10.1111/j.1600-0625.2007.00581.x.
|
| 186 |
Inflammatory cytokine-mediated induction of serine racemase in atopic dermatitis.J Cell Mol Med. 2018 Jun;22(6):3133-3138. doi: 10.1111/jcmm.13592. Epub 2018 Mar 22.
|
| 187 |
Glyteer, Soybean Tar, Impairs IL-4/Stat6 Signaling in Murine Bone Marrow-Derived Dendritic Cells: The Basis of Its Therapeutic Effect on Atopic Dermatitis.Int J Mol Sci. 2018 Apr 12;19(4):1169. doi: 10.3390/ijms19041169.
|
| 188 |
The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate-to-severe atopic dermatitis: results from a randomized double-blind placebo-controlled study.Br J Dermatol. 2019 Oct;181(4):733-742. doi: 10.1111/bjd.17932. Epub 2019 May 6.
|
| 189 |
DNA methylation of Th2 lineage determination genes at birth is associated with allergic outcomes in childhood.Clin Exp Allergy. 2017 Dec;47(12):1599-1608. doi: 10.1111/cea.12988. Epub 2017 Aug 31.
|
| 190 |
Genetic variation in the epidermal transglutaminase genes is not associated with atopic dermatitis.PLoS One. 2012;7(11):e49694. doi: 10.1371/journal.pone.0049694. Epub 2012 Nov 26.
|
| 191 |
Analysis of the Association of Polymorphisms rs5743708 in TLR2 and rs4986790 in TLR4 with Atopic Dermatitis Risk.Immunol Invest. 2019 Feb;48(2):169-180. doi: 10.1080/08820139.2018.1508228. Epub 2018 Oct 1.
|
| 192 |
The association of genetic variants in toll-like receptor 2 subfamily with allergy and asthma after hospitalization for bronchiolitis in infancy.Pediatr Infect Dis J. 2014 May;33(5):463-6. doi: 10.1097/INF.0000000000000253.
|
| 193 |
Glucocorticoid-induced tumour necrosis factor receptor (GITR) and its ligand (GITRL) in atopic dermatitis.Acta Derm Venereol. 2006;86(5):393-8. doi: 10.2340/00015555-0118.
|
| 194 |
TWEAK mediates inflammation in experimental atopic dermatitis and psoriasis.Nat Commun. 2017 May 22;8:15395. doi: 10.1038/ncomms15395.
|
| 195 |
Nonhistaminergic and mechanical itch sensitization in atopic dermatitis.Pain. 2017 Sep;158(9):1780-1791. doi: 10.1097/j.pain.0000000000000980.
|
| 196 |
Efficacy and safety of PAC-14028 cream - a novel, topical, nonsteroidal, selective TRPV1 antagonist in patients with mild-to-moderate atopic dermatitis: a phase IIb randomized trial.Br J Dermatol. 2019 May;180(5):1030-1038. doi: 10.1111/bjd.17455. Epub 2019 Jan 8.
|
| 197 |
Inhibition of the Warm Temperature-Activated Ca(2+)-Permeable Transient Receptor Potential Vanilloid TRPV3 Channel Attenuates Atopic Dermatitis.Mol Pharmacol. 2019 Sep;96(3):393-400. doi: 10.1124/mol.119.116962. Epub 2019 Jul 15.
|
| 198 |
Development of a new eczema-like reconstructed skin equivalent for testing child atopic dermatitis-relieving cosmetics.J Cosmet Dermatol. 2020 Mar;19(3):752-757. doi: 10.1111/jocd.13069. Epub 2019 Jul 17.
|
| 199 |
Down-regulation of vasoactive intestinal polypeptide receptor expression in atopic dermatitis.J Allergy Clin Immunol. 2003 May;111(5):1099-105. doi: 10.1067/mai.2003.1477.
|
| 200 |
Assessment and Clinical Relevance of Serum IL-19 Levels in Psoriasis and Atopic Dermatitis Using a Sensitive and Specific Novel Immunoassay.Sci Rep. 2019 Mar 26;9(1):5211. doi: 10.1038/s41598-019-41609-z.
|
| 201 |
Iron and infection: effects of host iron status and the iron-regulatory genes haptoglobin and NRAMP1 (SLC11A1) on host-pathogen interactions in tuberculosis and HIV.Clin Sci (Lond). 2006 May;110(5):503-24. doi: 10.1042/CS20050273.
|
| 202 |
Sweat glucose and GLUT2 expression in atopic dermatitis: Implication for clinical manifestation and treatment.PLoS One. 2018 Apr 20;13(4):e0195960. doi: 10.1371/journal.pone.0195960. eCollection 2018.
|
| 203 |
A rare variant in CYP27A1 and its association with atopic dermatitis with high serum total IgE.Allergy. 2016 Oct;71(10):1486-9. doi: 10.1111/all.12950. Epub 2016 Aug 3.
|
| 204 |
Glycoproteomic studies of IgE from a novel hyper IgE syndrome linked to PGM3 mutation.Glycoconj J. 2016 Jun;33(3):447-56. doi: 10.1007/s10719-015-9638-y. Epub 2015 Dec 19.
|
| 205 |
Aldo-keto reductase 1C3 is expressed in differentiated human epidermis, affects keratinocyte differentiation, and is upregulated in atopic dermatitis.J Invest Dermatol. 2012 Apr;132(4):1103-10. doi: 10.1038/jid.2011.412. Epub 2011 Dec 15.
|
| 206 |
Transglutaminase 3 Promotes Skin Inflammation in Atopic Dermatitis by Activating Monocyte-Derived Dendritic Cells via DC-SIGN.J Invest Dermatol. 2020 Feb;140(2):370-379.e8. doi: 10.1016/j.jid.2019.07.703. Epub 2019 Aug 16.
|
| 207 |
Bleomycin hydrolase is regulated biphasically in a differentiation- and cytokine-dependent manner: relevance to atopic dermatitis. J Biol Chem. 2011 Mar 11;286(10):8204-12.
|
| 208 |
Sweat lipid mediator profiling: a noninvasive approach for cutaneous research.J Lipid Res. 2017 Jan;58(1):188-195. doi: 10.1194/jlr.M071738. Epub 2016 Nov 8.
|
| 209 |
Red ginseng extracts attenuate skin inflammation in atopic dermatitis through p70 ribosomal protein S6 kinase activation.J Pharmacol Sci. 2018 Jan;136(1):9-15. doi: 10.1016/j.jphs.2017.11.002. Epub 2017 Nov 10.
|
| 210 |
Predicting therapy response to mycophenolic acid using UGT1A9 genotyping: towards personalized medicine in atopic dermatitis.J Dermatolog Treat. 2017 May;28(3):242-245. doi: 10.1080/09546634.2016.1227420. Epub 2016 Sep 13.
|
| 211 |
Apamin inhibits TNF-- and IFN--induced inflammatory cytokines and chemokines via suppressions of NF-B signaling pathway and STAT in human keratinocytes.Pharmacol Rep. 2017 Oct;69(5):1030-1035. doi: 10.1016/j.pharep.2017.04.006. Epub 2017 Apr 18.
|
| 212 |
Lactobacillus plantarum NCIMB8826 ameliorates inflammation of colon and skin in human APOC1 transgenic mice.Benef Microbes. 2016;7(2):215-25. doi: 10.3920/BM2015.0074. Epub 2015 Dec 21.
|
| 213 |
Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2.J Dermatolog Treat. 2020 Sep;31(6):606-614. doi: 10.1080/09546634.2019.1612836. Epub 2019 Jun 9.
|
| 214 |
Bcl-3 acts as an innate immune modulator by controlling antimicrobial responses in keratinocytes.J Invest Dermatol. 2009 Sep;129(9):2148-55. doi: 10.1038/jid.2009.49. Epub 2009 Mar 12.
|
| 215 |
CARD11 is dispensable for homeostatic responses and suppressive activity of peripherally induced FOXP3(+) regulatory T cells.Immunol Cell Biol. 2019 Sep;97(8):740-752. doi: 10.1111/imcb.12268. Epub 2019 Jun 26.
|
| 216 |
IL-4 regulates chemokine CCL26 in keratinocytes through the Jak1, 2/Stat6 signal transduction pathway: Implication for atopic dermatitis.Mol Immunol. 2012 Feb;50(1-2):91-7. doi: 10.1016/j.molimm.2011.12.008. Epub 2012 Jan 5.
|
| 217 |
Mechanisms of IFN--induced apoptosis of human skin keratinocytes in patients with atopic dermatitis.J Allergy Clin Immunol. 2012 May;129(5):1297-306. doi: 10.1016/j.jaci.2012.02.020. Epub 2012 Mar 24.
|
| 218 |
CD1c+ Blood Dendritic Cells in Atopic Dermatitis are Premature and Can Produce Disease-specific Chemokines.Acta Derm Venereol. 2017 Mar 10;97(3):325-331. doi: 10.2340/00015555-2540.
|
| 219 |
Changes in salivary chromogranin A levels in adults with atopic dermatitis are correlated with changes in their condition.J Dermatol. 2018 May;45(5):554-559. doi: 10.1111/1346-8138.14277. Epub 2018 Mar 3.
|
| 220 |
Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis.J Allergy Clin Immunol. 2019 Oct;144(4):1011-1024. doi: 10.1016/j.jaci.2019.07.013. Epub 2019 Jul 26.
|
| 221 |
Oral treatment with Aloe polysaccharide ameliorates ovalbumin-induced atopic dermatitis by restoring tight junctions in skin.Scand J Immunol. 2020 Mar;91(3):e12856. doi: 10.1111/sji.12856. Epub 2019 Dec 19.
|
| 222 |
Atopic Dermatitis According to GARP: New Mechanistic Insights in Disease Pathogenesis.J Invest Dermatol. 2016 Dec;136(12):2340-2341. doi: 10.1016/j.jid.2016.08.020.
|
| 223 |
Differential expression of CRABP II, psoriasin and cytokeratin 1 mRNA in human skin diseases.Arch Dermatol Res. 1996 Jul;288(8):426-30. doi: 10.1007/BF02505229.
|
| 224 |
Persistent kallikrein 5 activation induces atopic dermatitis-like skin architecture independent of PAR2 activity.J Allergy Clin Immunol. 2017 Nov;140(5):1310-1322.e5. doi: 10.1016/j.jaci.2017.01.025. Epub 2017 Feb 24.
|
| 225 |
Association of polymorphisms in the promoter region of FCER1A gene with atopic dermatitis, chronic uticaria, asthma, and serum immunoglobulin E levels in a Han Chinese population.Hum Immunol. 2012 Mar;73(3):301-5. doi: 10.1016/j.humimm.2011.12.001. Epub 2011 Dec 11.
|
| 226 |
miR-10a-5p is increased in atopic dermatitis and has capacity to inhibit keratinocyte proliferation.Allergy. 2019 Nov;74(11):2146-2156. doi: 10.1111/all.13849. Epub 2019 Jun 6.
|
| 227 |
Genetic association studies between the T cell immunoglobulin mucin (TIM) gene locus and childhood atopic dermatitis.Int Arch Allergy Immunol. 2006;141(4):331-6. doi: 10.1159/000095459. Epub 2006 Aug 29.
|
| 228 |
The Major Orphan Forms of Ichthyosis Are Characterized by Systemic T-Cell Activation and Th-17/Tc-17/Th-22/Tc-22 Polarization in Blood.J Invest Dermatol. 2018 Oct;138(10):2157-2167. doi: 10.1016/j.jid.2018.03.1523. Epub 2018 Apr 14.
|
| 229 |
Expression of Cornified Envelope Proteins in Skin and Its Relationship with Atopic Dermatitis Phenotype.Acta Derm Venereol. 2017 Jan 4;97(1):36-41. doi: 10.2340/00015555-2482.
|
| 230 |
Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6.Clin Immunol. 2008 Mar;126(3):332-7. doi: 10.1016/j.clim.2007.11.006. Epub 2007 Dec 31.
|
| 231 |
Prediction of atopic dermatitis in 2-yr-old children by cord blood IgE, genetic polymorphisms in cytokine genes, and maternal mentality during pregnancy.Pediatr Allergy Immunol. 2011 Nov;22(7):695-703. doi: 10.1111/j.1399-3038.2011.01177.x. Epub 2011 May 4.
|
| 232 |
Type 2 helper T-cell cytokines induce morphologic and molecular characteristics of atopic dermatitis in human skin equivalent.Am J Pathol. 2011 May;178(5):2091-9. doi: 10.1016/j.ajpath.2011.01.037.
|
| 233 |
The IL-13-OVOL1-FLG axis in atopic dermatitis.Immunology. 2019 Dec;158(4):281-286. doi: 10.1111/imm.13120. Epub 2019 Oct 1.
|
| 234 |
Eosinophil-derived neurotoxin as a biomarker for disease severity and relapse in recalcitrant atopic dermatitis.Ann Allergy Asthma Immunol. 2017 Nov;119(5):441-445. doi: 10.1016/j.anai.2017.06.022. Epub 2017 Aug 31.
|
| 235 |
Genetic association analyses of atopic illness and proinflammatory cytokine genes with type 1 diabetes.Diabetes Metab Res Rev. 2011 Nov;27(8):838-43. doi: 10.1002/dmrr.1259.
|
| 236 |
Correlation of KIF3A and OVOL1, but not ACTL9, with atopic dermatitis in Chinese pediatric patients.Gene. 2015 Oct 25;571(2):249-51. doi: 10.1016/j.gene.2015.06.068. Epub 2015 Jun 27.
|
| 237 |
Spontaneous atopic dermatitis due to immune dysregulation in mice lacking Adamts2 and 14.Matrix Biol. 2018 Sep;70:140-157. doi: 10.1016/j.matbio.2018.04.002. Epub 2018 Apr 9.
|
| 238 |
Atopic dermatitis complicated by eczema herpeticum is associated with HLA B7 and reduced interferon--producing CD8+ T cells.Br J Dermatol. 2013 Sep;169(3):700-3. doi: 10.1111/bjd.12382.
|
| 239 |
Phosphodiesterase 4 Inhibitor Therapies for Atopic Dermatitis: Progress and Outlook.Drugs. 2017 Sep;77(13):1389-1397. doi: 10.1007/s40265-017-0784-3.
|
| 240 |
Tezepelumab, an anti-thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial.J Am Acad Dermatol. 2019 Apr;80(4):1013-1021. doi: 10.1016/j.jaad.2018.11.059. Epub 2018 Dec 12.
|
| 241 |
Keratinocyte-derived anosmin-1, an extracellular glycoprotein encoded by the X-linked Kallmann syndrome gene, is involved in modulation of epidermal nerve density in atopic dermatitis.J Dermatol Sci. 2010 Apr;58(1):64-71. doi: 10.1016/j.jdermsci.2010.02.010. Epub 2010 Feb 20.
|
| 242 |
The expression of BAFF, APRIL and TWEAK is altered in eczema skin but not in the circulation of atopic and seborrheic eczema patients.PLoS One. 2011;6(7):e22202. doi: 10.1371/journal.pone.0022202. Epub 2011 Jul 13.
|
| 243 |
Protein tyrosine phosphatase conjugated with a novel transdermal delivery peptide, astrotactin 1-derived peptide recombinant protein tyrosine phosphatase (AP-rPTP), alleviates both atopic dermatitis-like and psoriasis-like dermatitis.J Allergy Clin Immunol. 2018 Jan;141(1):137-151. doi: 10.1016/j.jaci.2017.04.007. Epub 2017 Apr 26.
|
| 244 |
Selective ablation of Ctip2/Bcl11b in epidermal keratinocytes triggers atopic dermatitis-like skin inflammatory responses in adult mice.PLoS One. 2012;7(12):e51262. doi: 10.1371/journal.pone.0051262. Epub 2012 Dec 20.
|
| 245 |
Association between Stress and the HPA Axis in the Atopic Dermatitis.Int J Mol Sci. 2017 Oct 12;18(10):2131. doi: 10.3390/ijms18102131.
|
| 246 |
Tiled array-based sequencing identifies enrichment of loss-of-function variants in the highly homologous filaggrin gene in African-American children with severe atopic dermatitis.Exp Dermatol. 2018 Sep;27(9):989-992. doi: 10.1111/exd.13691. Epub 2018 Jun 28.
|
| 247 |
Off-label Uses of Topical Pimecrolimus.J Cutan Med Surg. 2019 Jul/Aug;23(4):442-448. doi: 10.1177/1203475419847950. Epub 2019 May 3.
|
| 248 |
Pyrrolidone carboxylic acid levels or caspase-14 expression in the corneocytes of lesional skin correlates with clinical severity, skin barrier function and lesional inflammation in atopic dermatitis.J Dermatol Sci. 2014 Dec;76(3):231-9. doi: 10.1016/j.jdermsci.2014.09.004. Epub 2014 Sep 30.
|
| 249 |
Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population.Nat Genet. 2012 Nov;44(11):1222-6. doi: 10.1038/ng.2438. Epub 2012 Oct 7.
|
| 250 |
Ionizing radiation promotes CCL27 secretion from keratinocytes through the cross talk between TNF- and ROS.J Biochem Mol Toxicol. 2017 Mar;31(3). doi: 10.1002/jbt.21868. Epub 2016 Nov 23.
|
| 251 |
Toll-like receptor 4 attenuates a murine model of atopic dermatitis through inhibition of langerin-positive DCs migration.Exp Dermatol. 2018 Sep;27(9):1015-1022. doi: 10.1111/exd.13698. Epub 2018 Jul 20.
|
| 252 |
The CD48 receptor mediates Staphylococcus aureus human and murine eosinophil activation.Clin Exp Allergy. 2014 Nov;44(11):1335-46. doi: 10.1111/cea.12422.
|
| 253 |
Temperature-controlled laminar airflow (TLA) device in the treatment of children with severe atopic eczema: Open-label, proof-of-concept study.Clin Exp Allergy. 2018 May;48(5):594-603. doi: 10.1111/cea.13105. Epub 2018 Mar 13.
|
| 254 |
Association of CDKAL1 Polymorphisms with Early-Onset Atopic Dermatitis in Koreans.Ann Dermatol. 2018 Jun;30(3):276-283. doi: 10.5021/ad.2018.30.3.276. Epub 2018 Apr 23.
|
| 255 |
IFN- Reduces Epidermal Barrier Function by Affecting Fatty Acid Composition of Ceramide in a Mouse Atopic Dermatitis Model.J Immunol Res. 2019 Jan 29;2019:3030268. doi: 10.1155/2019/3030268. eCollection 2019.
|
| 256 |
Ceramide synthase 4 is highly expressed in involved skin of patients with atopic dermatitis.J Eur Acad Dermatol Venereol. 2017 Jan;31(1):135-141. doi: 10.1111/jdv.13777. Epub 2016 Jun 29.
|
| 257 |
Human S100A15 splice variants are differentially expressed in inflammatory skin diseases and regulated through Th1 cytokines and calcium.Exp Dermatol. 2007 Aug;16(8):685-91. doi: 10.1111/j.1600-0625.2007.00587.x.
|
| 258 |
Chemokine-like factor 1 (CLFK1) is over-expressed in patients with atopic dermatitis.Int J Biol Sci. 2013 Aug 13;9(8):759-65. doi: 10.7150/ijbs.6291. eCollection 2013.
|
| 259 |
Claudin-3 Loss Causes Leakage of Sweat from the Sweat Gland to Contribute to the Pathogenesis of Atopic Dermatitis.J Invest Dermatol. 2018 Jun;138(6):1279-1287. doi: 10.1016/j.jid.2017.11.040. Epub 2017 Dec 23.
|
| 260 |
A comprehensive analysis of pattern recognition receptors in normal and inflamed human epidermis: upregulation of dectin-1 in psoriasis.J Invest Dermatol. 2010 Nov;130(11):2611-20. doi: 10.1038/jid.2010.196. Epub 2010 Jul 15.
|
| 261 |
Atopic Eczema: Genetic Analysis of COL6A5, COL8A1, and COL10A1 in Mediterranean Populations.Biomed Res Int. 2019 Jun 4;2019:3457898. doi: 10.1155/2019/3457898. eCollection 2019.
|
| 262 |
Identification of novel candidate variants including COL6A6 polymorphisms in early-onset atopic dermatitis using whole-exome sequencing.BMC Med Genet. 2017 Jan 26;18(1):8. doi: 10.1186/s12881-017-0368-9.
|
| 263 |
Investigation of the eotaxin gene -426C-->T, -384A-->G and 67G-->a single-nucleotide polymorphisms and atopic dermatitis in Italian children using family-based association methods.Clin Exp Dermatol. 2008 May;33(3):316-21. doi: 10.1111/j.1365-2230.2007.02672.x. Epub 2008 Feb 28.
|
| 264 |
Altered Expression of Genes Encoding Cornulin and Repetin in Atopic Dermatitis.Int Arch Allergy Immunol. 2017;172(1):11-19. doi: 10.1159/000453452. Epub 2017 Feb 21.
|
| 265 |
A nonsynonymous substitution of cystatin A, a cysteine protease inhibitor of house dust mite protease, leads to decreased mRNA stability and shows a significant association with atopic dermatitis.Allergy. 2007 May;62(5):514-9. doi: 10.1111/j.1398-9995.2007.01350.x.
|
| 266 |
No evidence for an association between a variant of the mast cell chymase gene and atopic dermatitis based on case-control and haplotype-relative-risk analyses.Hum Hered. 1998 Sep-Oct;48(5):271-4. doi: 10.1159/000022815.
|
| 267 |
Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo.J Immunol. 2005 Jun 15;174(12):8003-10. doi: 10.4049/jimmunol.174.12.8003.
|
| 268 |
A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis.Hum Mol Genet. 2013 Dec 1;22(23):4841-56. doi: 10.1093/hmg/ddt317. Epub 2013 Jul 25.
|
| 269 |
Hint for association of single nucleotide polymorphisms and haplotype in SPINK5 gene with atopic dermatitis in Koreans.Exp Dermatol. 2010 Dec;19(12):1048-53. doi: 10.1111/j.1600-0625.2010.01142.x.
|
| 270 |
Activity, expression and genetic variation of canine -defensin 103: a multifunctional antimicrobial peptide in the skin of domestic dogs.J Innate Immun. 2012;4(3):248-59. doi: 10.1159/000334566. Epub 2012 Jan 19.
|
| 271 |
Topical Application of Josamycin Inhibits Development of Atopic Dermatitis-Like Skin Lesions in NC/Nga Mice.J Pharm Pharm Sci. 2017;20:38-47. doi: 10.18433/J3GW3D.
|
| 272 |
Homeostatic Function of Dermokine in the Skin Barrier and Inflammation.J Invest Dermatol. 2020 Apr;140(4):838-849.e9. doi: 10.1016/j.jid.2019.09.011. Epub 2019 Oct 25.
|
| 273 |
Expression of keratin 1, keratin 10, desmoglein 1 and desmocollin 1 in the epidermis: possible downregulation by interleukin-4 and interleukin-13 in atopic dermatitis.Eur J Dermatol. 2017 Jun 1;27(3):247-253. doi: 10.1684/ejd.2017.2985.
|
| 274 |
Swiprosin-1 is expressed in mast cells and up-regulated through the protein kinase C beta I/eta pathway.J Cell Biochem. 2009 Oct 15;108(3):705-15. doi: 10.1002/jcb.22307.
|
| 275 |
Staphylococcal enterotoxins modulate the effector CD4(+) T cell response by reshaping the gene expression profile in adults with atopic dermatitis.Sci Rep. 2019 Sep 11;9(1):13082. doi: 10.1038/s41598-019-49421-5.
|
| 276 |
Expression of endomucin, a novel endothelial sialomucin, in normal and diseased human skin.J Invest Dermatol. 2002 Dec;119(6):1388-93. doi: 10.1046/j.1523-1747.2002.19647.x.
|
| 277 |
Early-onset pediatric atopic dermatitis is characterized by T(H)2/T(H)17/T(H)22-centered inflammation and lipid alterations.J Allergy Clin Immunol. 2018 Jun;141(6):2094-2106. doi: 10.1016/j.jaci.2018.02.040. Epub 2018 May 3.
|
| 278 |
Cloning and characterization of the highly expressed ETEA gene from blood cells of atopic dermatitis patients.Biochem Biophys Res Commun. 2002 Oct 11;297(5):1282-90. doi: 10.1016/s0006-291x(02)02380-x.
|
| 279 |
Supplemental feeding of phospholipid-enriched alkyl phospholipid from krill relieves spontaneous atopic dermatitis and strengthens skin intercellular lipid barriers in NC/Nga mice.Biosci Biotechnol Biochem. 2019 Apr;83(4):717-727. doi: 10.1080/09168451.2018.1559024. Epub 2018 Dec 20.
|
| 280 |
Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways.BMC Med Genomics. 2015 Oct 12;8:60. doi: 10.1186/s12920-015-0133-x.
|
| 281 |
IL-1 induces thymic stromal lymphopoietin and an atopic dermatitis-like phenotype in reconstructed healthy human epidermis.J Pathol. 2017 Jun;242(2):234-245. doi: 10.1002/path.4887. Epub 2017 Apr 6.
|
| 282 |
Insight into the redox status of inflammatory skin equivalents as determined by EPR spectroscopy.Chem Biol Interact. 2019 Sep 1;310:108752. doi: 10.1016/j.cbi.2019.108752. Epub 2019 Jul 19.
|
| 283 |
The potential role of impaired Notch signalling in atopic dermatitis.Acta Derm Venereol. 2015 Jan;95(1):5-11. doi: 10.2340/00015555-1898.
|
| 284 |
Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions.J Allergy Clin Immunol. 2000 Jun;105(6 Pt 1):1211-20. doi: 10.1067/mai.2000.107039.
|
| 285 |
Transient epidermal barrier deficiency and lowered allergic threshold in filaggrin-hornerin (FlgHrnr(-/-) ) double-deficient mice.Allergy. 2019 Jul;74(7):1327-1339. doi: 10.1111/all.13756. Epub 2019 Apr 15.
|
| 286 |
Targeted deep sequencing identifies rare loss-of-function variants in IFNGR1 for risk of atopic dermatitis complicated by eczema herpeticum.J Allergy Clin Immunol. 2015 Dec;136(6):1591-1600. doi: 10.1016/j.jaci.2015.06.047. Epub 2015 Sep 3.
|
| 287 |
Differential IL-10 receptor gene expression in acute versus chronic atopic eczema. Modulation by immunosuppressive drugs and cytokines in normal cultured keratinocytes.Inflamm Res. 1999 Oct;48(10):539-43. doi: 10.1007/s000110050500.
|
| 288 |
Increased IL-26 Expression Promotes T Helper Type 17- and T Helper Type 2-Associated Cytokine Production by Keratinocytes in AtopicDermatitis.J Invest Dermatol. 2020 Mar;140(3):636-644.e2. doi: 10.1016/j.jid.2019.07.713. Epub 2019 Aug 26.
|
| 289 |
IL-9 induces VEGF secretion from human mast cells and IL-9/IL-9 receptor genes are overexpressed in atopic dermatitis.PLoS One. 2012;7(3):e33271. doi: 10.1371/journal.pone.0033271. Epub 2012 Mar 8.
|
| 290 |
Genetic variants in interferon regulatory factor 2 (IRF2) are associated with atopic dermatitis and eczema herpeticum.J Invest Dermatol. 2012 Mar;132(3 Pt 1):650-7. doi: 10.1038/jid.2011.374. Epub 2011 Nov 24.
|
| 291 |
Intelectin contributes to allergen-induced IL-25, IL-33, and TSLP expression and type 2 response in asthma and atopic dermatitis.Mucosal Immunol. 2017 Nov;10(6):1491-1503. doi: 10.1038/mi.2017.10. Epub 2017 Feb 22.
|
| 292 |
Atopic Dermatitis-like Graft-versus-host Disease and Lichen Planus-like Graft-versus-host Disease: Alterations in Skin Barrier Function and Related Molecules.Chin Med J (Engl). 2017 Jun 20;130(12):1459-1466. doi: 10.4103/0366-6999.207475.
|
| 293 |
Early cutaneous gene transcription changes in adult atopic dermatitis and potential clinical implications.Exp Dermatol. 2007 Jan;16(1):28-36. doi: 10.1111/j.1600-0625.2006.00504.x.
|
| 294 |
Polymorphisms of the Bcl-2 family member bfl-1 in children with atopic dermatitis.Pediatr Allergy Immunol. 2006 Dec;17(8):578-82. doi: 10.1111/j.1399-3038.2006.00468.x.
|
| 295 |
Osthole attenuates mouse atopic dermatitis by inhibiting thymic stromal lymphopoietin production from keratinocytes.Exp Dermatol. 2019 May;28(5):561-567. doi: 10.1111/exd.13910.
|
| 296 |
Keratinocyte Proline-Rich Protein DeficiencyinAtopic Dermatitis Leads to Barrier Disruption.J Invest Dermatol. 2019 Sep;139(9):1867-1875.e7. doi: 10.1016/j.jid.2019.02.030. Epub 2019 Mar 21.
|
| 297 |
Explant cultures of atopic dermatitis biopsies maintain their epidermal characteristics in vitro.Cell Tissue Res. 2015 Sep;361(3):789-97. doi: 10.1007/s00441-015-2162-3. Epub 2015 Mar 18.
|
| 298 |
IL-33-Induced Atopic Dermatitis-Like Inflammation in Mice Is Mediated by Group 2 Innate Lymphoid Cells in Concert with Basophils.J Invest Dermatol. 2019 Oct;139(10):2185-2194.e3. doi: 10.1016/j.jid.2019.04.016. Epub 2019 May 21.
|
| 299 |
An Integrated Model of Atopic Dermatitis Biomarkers Highlights the Systemic Nature of the Disease.J Invest Dermatol. 2017 Mar;137(3):603-613. doi: 10.1016/j.jid.2016.09.037. Epub 2016 Nov 4.
|
| 300 |
The effects of season and weather on healthcare utilization among patients with atopic dermatitis.J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1745-1753. doi: 10.1111/jdv.15023. Epub 2018 May 31.
|
| 301 |
Vaccinia virus binds to the scavenger receptor MARCO on the surface of keratinocytes.J Invest Dermatol. 2015 Jan;135(1):142-150. doi: 10.1038/jid.2014.330. Epub 2014 Aug 4.
|
| 302 |
Identification of candidate genes in atopic dermatitis based on bioinformatic methods.Int J Dermatol. 2016 Jul;55(7):791-800. doi: 10.1111/ijd.13291. Epub 2016 Mar 9.
|
| 303 |
Investigation of the chromosome 17q25 PSORS2 locus in atopic dermatitis.J Invest Dermatol. 2006 Mar;126(3):603-6. doi: 10.1038/sj.jid.5700108.
|
| 304 |
Targeted disruption of MAIL, a nuclear IkappaB protein, leads to severe atopic dermatitis-like disease.J Biol Chem. 2004 Dec 31;279(53):55493-8. doi: 10.1074/jbc.M409770200. Epub 2004 Oct 18.
|
| 305 |
Linkage and association to candidate regions in Swedish atopic dermatitis families.Hum Genet. 2001 Aug;109(2):129-35. doi: 10.1007/s004390100556.
|
| 306 |
Is there an association between indoor allergens and the severity of atopic dermatitis?.Int J Dermatol. 2019 Apr;58(4):433-439. doi: 10.1111/ijd.14281. Epub 2018 Nov 23.
|
| 307 |
Neuroplastin- mediates S100A8/A9-induced lung cancer disseminative progression.Mol Carcinog. 2019 Jun;58(6):980-995. doi: 10.1002/mc.22987. Epub 2019 Feb 27.
|
| 308 |
Specificity protein 1 is pivotal in the skin's antiviral response.J Allergy Clin Immunol. 2011 Feb;127(2):430-438.e1-2. doi: 10.1016/j.jaci.2010.11.013. Epub 2011 Jan 5.
|
| 309 |
Amphiphilic Triazine Polymer Derivatives as Antibacterial And Anti-atopic Agents in Mice Model.Sci Rep. 2019 Oct 22;9(1):15161. doi: 10.1038/s41598-019-51561-7.
|
| 310 |
The PCDH1 gene and asthma in early childhood.Eur Respir J. 2014 Mar;43(3):792-800. doi: 10.1183/09031936.00021613. Epub 2013 Aug 29.
|
| 311 |
Hypoxia inhibits TNF--induced TSLP expression in keratinocytes.PLoS One. 2019 Nov 4;14(11):e0224705. doi: 10.1371/journal.pone.0224705. eCollection 2019.
|
| 312 |
Functional characterization of the atopy-associated gene PHF11.J Allergy Clin Immunol. 2008 May;121(5):1148-1154.e3. doi: 10.1016/j.jaci.2008.02.028. Epub 2008 Apr 11.
|
| 313 |
The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult long-standing disease.J Am Acad Dermatol. 2019 Aug;81(2):510-519. doi: 10.1016/j.jaad.2019.04.036. Epub 2019 Apr 19.
|
| 314 |
Phosphodiesterase 4D, miR-203 and selected cytokines in the peripheral blood are associated with canine atopic dermatitis.PLoS One. 2019 Jun 21;14(6):e0218670. doi: 10.1371/journal.pone.0218670. eCollection 2019.
|
| 315 |
Multiple regulatory variants located in cell type-specific enhancers within the PKP2 locus form major risk and protective haplotypes for canine atopic dermatitis in German shepherd dogs.BMC Genet. 2016 Jun 29;17(1):97. doi: 10.1186/s12863-016-0404-3.
|
| 316 |
Cloning of a gene for a novel epithelium-specific cytosolic phospholipase A2, cPLA2delta, induced in psoriatic skin.J Biol Chem. 2004 Mar 26;279(13):12890-7. doi: 10.1074/jbc.M305801200. Epub 2004 Jan 6.
|
| 317 |
Critical role for mast cell Stat5 activity in skin inflammation.Cell Rep. 2014 Jan 30;6(2):366-76. doi: 10.1016/j.celrep.2013.12.029. Epub 2014 Jan 9.
|
| 318 |
Increasing severity of atopic dermatitis is associated with a negative impact on work productivity among adults with atopic dermatitis in France, Germany, the U.K. and the U.S.A.Br J Dermatol. 2020 Apr;182(4):1007-1016. doi: 10.1111/bjd.18296. Epub 2019 Sep 8.
|
| 319 |
CD100-Plexin-B2 Promotes the Inflammation in Psoriasis by Activating NF-B and the Inflammasome inKeratinocytes.J Invest Dermatol. 2018 Feb;138(2):375-383. doi: 10.1016/j.jid.2017.09.005. Epub 2017 Sep 18.
|
| 320 |
Elevated platelet activation in patients with atopic dermatitis and psoriasis: increased plasma levels of beta-thromboglobulin and platelet factor 4.Allergol Int. 2008 Dec;57(4):391-6. doi: 10.2332/allergolint.O-08-537. Epub 2008 Dec 1.
|
| 321 |
Genome-wide association study identifies two new susceptibility loci for atopic dermatitis in the Chinese Han population.Nat Genet. 2011 Jun 12;43(7):690-4. doi: 10.1038/ng.851.
|
| 322 |
Association of Single-Nucleotide Polymorphisms of the MBL2 with Atopic Dermatitis in Korean Patients.Ann Dermatol. 2017 Oct;29(5):571-577. doi: 10.5021/ad.2017.29.5.571. Epub 2017 Aug 25.
|
| 323 |
The effect of autophagy-enhancing peptide in moisturizer on atopic dermatitis: a randomized controlled trial.J Dermatolog Treat. 2019 Sep;30(6):558-564. doi: 10.1080/09546634.2018.1544407. Epub 2018 Dec 2.
|
| 324 |
Association analyses identify two susceptibility loci 5q31 and 5q22.1 for atopic dermatitis in Chinese Han population.Asian Pac J Allergy Immunol. 2017 Dec;35(4):196-202. doi: 10.12932/AP0869.
|
| 325 |
Mice lacking the transcription factor RelB develop T cell-dependent skin lesions similar to human atopic dermatitis.Eur J Immunol. 2000 Aug;30(8):2323-32. doi: 10.1002/1521-4141(2000)30:8<2323::AID-IMMU2323>3.0.CO;2-H.
|
| 326 |
Distinct gene expression patterns of peripheral blood cells in hyper-IgE syndrome.Clin Exp Immunol. 2005 Jun;140(3):524-31. doi: 10.1111/j.1365-2249.2005.02805.x.
|
| 327 |
Unique profile of antimicrobial peptide expression in polymorphic light eruption lesions compared to healthy skin, atopic dermatitis, and psoriasis.Photodermatol Photoimmunol Photomed. 2018 Mar;34(2):137-144. doi: 10.1111/phpp.12355. Epub 2017 Nov 13.
|
| 328 |
A genome-wide association study reveals 2 new susceptibility loci for atopic dermatitis.J Allergy Clin Immunol. 2015 Sep;136(3):802-6. doi: 10.1016/j.jaci.2015.01.047. Epub 2015 Apr 10.
|
| 329 |
Burden of Atopic Dermatitis in the United States: Analysis of Healthcare Claims Data in the Commercial, Medicare, and Medi-Cal Databases.Adv Ther. 2017 Aug;34(8):1989-2006. doi: 10.1007/s12325-017-0582-z. Epub 2017 Jul 13.
|
| 330 |
Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis.PLoS One. 2017 Jul 14;12(7):e0181486. doi: 10.1371/journal.pone.0181486. eCollection 2017.
|
| 331 |
Decreased expression of suprabasin induces aberrant differentiation and apoptosis of epidermal keratinocytes: Possible role for atopic dermatitis.J Dermatol Sci. 2019 Sep;95(3):107-112. doi: 10.1016/j.jdermsci.2019.07.009. Epub 2019 Jul 27.
|
| 332 |
An inhibitory role for Sema4A in antigen-specific allergic asthma.J Clin Immunol. 2013 Jan;33(1):200-9. doi: 10.1007/s10875-012-9798-5. Epub 2012 Sep 25.
|
| 333 |
Serum squamous cell carcinoma antigen (SCCA)-2 correlates with clinical severity of pediatric atopic dermatitis in Ishigaki cohort.J Dermatol Sci. 2019 Aug;95(2):70-75. doi: 10.1016/j.jdermsci.2019.07.005. Epub 2019 Jul 24.
|
| 334 |
The role of Staphylococcus aureus in atopic dermatitis: microbiological and immunological implications.Postepy Dermatol Alergol. 2019 Aug;36(4):485-491. doi: 10.5114/ada.2018.77056. Epub 2019 Aug 30.
|
| 335 |
Profiling of epidermal lipids in a mouse model of dermatitis: Identification of potential biomarkers.PLoS One. 2018 Apr 26;13(4):e0196595. doi: 10.1371/journal.pone.0196595. eCollection 2018.
|
| 336 |
Irradiation with 310 nm and 340 nm ultraviolet light-emitting-diodes can improve atopic dermatitis-like skin lesions in NC/Nga mice.Photochem Photobiol Sci. 2018 Aug 8;17(8):1127-1135. doi: 10.1039/c8pp00063h.
|
| 337 |
Differential expression of mRNA for Th1 and Th2 cytokine-associated transcription factors and suppressors of cytokine signalling in peripheral blood mononuclear cells of patients with atopic dermatitis.Clin Exp Immunol. 2004 Mar;135(3):505-10. doi: 10.1111/j.1365-2249.2004.02405.x.
|
| 338 |
The history of atopic dermatitis.Clin Dermatol. 2017 Jul-Aug;35(4):344-348. doi: 10.1016/j.clindermatol.2017.03.005. Epub 2017 Mar 23.
|
| 339 |
Isolation of SPINK6 in human skin: selective inhibitor of kallikrein-related peptidases.J Biol Chem. 2010 Oct 15;285(42):32174-81. doi: 10.1074/jbc.M109.091850. Epub 2010 Jul 28.
|
| 340 |
Skin neurogenic inflammation.Semin Immunopathol. 2018 May;40(3):249-259. doi: 10.1007/s00281-018-0675-z. Epub 2018 Apr 30.
|
| 341 |
Upregulation of the transcript level of GTPase activating protein KIAA0603 in T cells from patients with atopic dermatitis.FEBS Lett. 2004 Aug 13;572(1-3):135-40. doi: 10.1016/j.febslet.2004.07.023.
|
| 342 |
Genome-wide analysis in German shepherd dogs reveals association of a locus on CFA 27 with atopic dermatitis.PLoS Genet. 2013 May;9(5):e1003475. doi: 10.1371/journal.pgen.1003475. Epub 2013 May 9.
|
| 343 |
Interferon- decreases ceramides with long-chain fatty acids: possible involvement in atopic dermatitis and psoriasis.J Invest Dermatol. 2014 Mar;134(3):712-718. doi: 10.1038/jid.2013.364. Epub 2013 Sep 5.
|
| 344 |
Atopic Eczema: Genetic Associations and Potential Links to Developmental Exposures.Int J Toxicol. 2017 May/Jun;36(3):187-198. doi: 10.1177/1091581817701075. Epub 2017 Mar 30.
|
| 345 |
Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion.J Clin Invest. 2006 Oct;116(10):2748-56. doi: 10.1172/JCI24274. Epub 2006 Sep 7.
|
| 346 |
TOX expression in different subtypes of cutaneous lymphoma.Arch Dermatol Res. 2014 Nov;306(9):843-9. doi: 10.1007/s00403-014-1501-7. Epub 2014 Sep 13.
|
| 347 |
An atopic dermatitis-like skin disease with hyper-IgE-emia develops in mice carrying a spontaneous recessive point mutation in the Traf3ip2 (Act1/CIKS) gene.J Immunol. 2010 Aug 15;185(4):2340-9. doi: 10.4049/jimmunol.0900694. Epub 2010 Jul 21.
|
| 348 |
Trim32 Deficiency Enhances Th2 Immunity and Predisposes to Features of Atopic Dermatitis.J Invest Dermatol. 2017 Feb;137(2):359-366. doi: 10.1016/j.jid.2016.09.020. Epub 2016 Oct 5.
|
| 349 |
CXCL17 Attenuates Imiquimod-Induced Psoriasis-like Skin Inflammation by Recruiting Myeloid-Derived Suppressor Cells and Regulatory T Cells.J Immunol. 2017 May 15;198(10):3897-3908. doi: 10.4049/jimmunol.1601607. Epub 2017 Apr 7.
|
| 350 |
IL-17C amplifies epithelial inflammation in human psoriasis and atopic eczema.J Eur Acad Dermatol Venereol. 2020 Apr;34(4):800-809. doi: 10.1111/jdv.16126. Epub 2020 Jan 19.
|
| 351 |
Arachidonate release and eicosanoid generation by group IIE phospholipase A(2).Biochem Biophys Res Commun. 2002 Apr 5;292(3):689-96. doi: 10.1006/bbrc.2002.6716.
|
|
|
|
|
|
|
